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The transcriptional activator ZNF143 is essential
for normal development in zebrafish
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Abstract
Background: ZNF143 is a sequence-specific DNA-binding protein that stimulates transcription of both small RNA
genes by RNA polymerase II or III, or protein-coding genes by RNA polymerase II, using separable activating
domains. We describe phenotypic effects following knockdown of this protein in developing Danio rerio (zebrafish)
embryos by injection of morpholino antisense oligonucleotides that target znf143 mRNA.
Results: The loss of function phenotype is pleiotropic and includes a broad array of abnormalities including
defects in heart, blood, ear and midbrain hindbrain boundary. Defects are rescued by coinjection of synthetic
mRNA encoding full-length ZNF143 protein, but not by protein lacking the amino-terminal activation domains.
Accordingly, expression of several marker genes is affected following knockdown, including GATA-binding protein
1 (gata1), cardiac myosin light chain 2 (cmlc2) and paired box gene 2a (pax2a). The zebrafish pax2a gene proximal
promoter contains two binding sites for ZNF143, and reporter gene transcription driven by this promoter in
transfected cells is activated by this protein.
Conclusions: Normal development of zebrafish embryos requires ZNF143. Furthermore, the pax2a gene is
probably one example of many protein-coding gene targets of ZNF143 during zebrafish development.
Background
The vertebrate transcriptional activator protein, ZNF143
(also known as STAF for selenocysteine tRNA gene tran-
scription activating factor, or SBF for SPH-binding factor)
operates at a multitude of small RNA and protein-coding
gene promoters [1-5]. Two separable activation domains
within this protein stimulate transcription selectively at
either small RNA or mRNA promoters [6]. Initially, atten-
tion was focused on the function of ZNF143 for small
RNA gene transcription, especially for vertebrate snRNA
and selenocysteine tRNA genes [7-9]. Then, several
mRNA genes were identified whose proximal promoters
contained SPH sites [10-15]. Possibly because of the highly
degenerate and relatively long DNA-binding site recog-
nized by ZNF143, it was not recognized for many years
that approximately 2000 mammalian protein-coding genes
contain SPH (SphI Postoctamer Homology [16]) elements,
or STAF Binding Sites (SBS), in their promoters [5].
Little is known concerning the phenotypic role(s) of
ZNF143 during cellular growth and animal development.
A number of cell-cycle-associated gene promoters are
regulated by ZNF143 [17-19]. Furthermore, ZNF143 is an
important regulator of mammalian embryonic stem cell
renewal [20,21]. At the molecular level, recent work has
demonstrated that this activator protein interacts with the
chromodomain-helicase-DNA binding protein 8 (CHD8),
and implicates that human U6 gene transcription is stimu-
lated by ZNF143 through this interaction [22]. Many
potential small RNA and protein-coding gene promoters
are targeted, but which are most pivotal in vivo?
We used zebrafish embryos as a model system to inves-
tigate the role of ZNF143 during vertebrate development.
Injection of translation-blocking morpholino oligonu-
cleotides (MOs) resulted in a pleiotropic phenotype
including axial defects as well as abnormalities in heart,
blood, ear and midbrain hindbrain boundary (MHB).
Coinjection of synthetic mRNA encoding zebrafish
ZNF143 rescued MO-induced defects, and rescue was
dependent on the amino-terminal region of the protein
containing activation domains. Expression levels or pat-
terns of the gata1, cmlc2, and pax2a genes were altered
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following MO knockdown of zebrafish ZNF143. The
pax2a gene is likely to be a direct target for ZNF143
because this protein binds the promoter in vitro and spe-
cific mutations in SPH sites resulted in reduced tran-
scription in transient transfection experiments.
Results
Identification of mRNA gene activation region in ZNF143
The zebrafish znf143 cDNA has been identified, and the
predicted amino acid sequence contains a high degree of
similarity with the human protein (71% overall identity by
our measurement) [23]. Furthermore, the zebrafish protein
contains highly conserved regions that correspond to the
previously identified DNA-binding domain (DBD), mRNA
gene activation domain (15 aa repeats) and small RNA
gene activation domain of the Xenopus and human pro-
teins [23] (Figure 1A). To verify the mRNA gene activating
potential of zebrafish ZNF143 and demarcate boundaries
of this region, we fused fragments encoding zebrafish
ZNF143 to the S. cerevisiae GAL4p DNA binding domain
(amino acids 1-94), and performed transient transfection
assays with such expression plasmids and a firefly lucifer-
ase reporter gene transcribed from a minimal promoter
driven by GAL4 binding sites. Because transcriptional acti-
vating domains of the Xenopus protein were localized to
the amino-terminal end previously [6], we investigated this
region only. Amino acids 13-150 of zebrafish ZNF143 con-
tains a potent mRNA gene activation region that functions
in both human embryonic kidney (HEK293) cells and zeb-
rafish ZF4 cells (Figure 1B, 1C). The region including only
the four 15 aa repeats (amino acids 47-150) was approxi-
mately three-fold less active in both cell types. However, it
is possible that this difference could be due to a lower
expression level of this fragment (Figure 1B). Importantly,
the region of zebrafish ZNF143 between the 15 aa repeats
and the zinc finger domain (amino acids 151-228) demon-
strated minimal mRNA promoter activation. Within this
region has been identified a small RNA gene activating
domain in the Xenopus protein [6].
Knockdown of ZNF143 in zebrafish embryos
To begin our studies with zebrafish embryos, we investi-
gated the expression of znf143 RNA using whole-mount
in situ hybridization. This RNA was expressed ubiqui-
tously in the early stages that we examined, including 2-4
cell stage embryos and through gastrulation stages (results
not shown). znf143 RNA must be inherited maternally,
since it was detected prior to onset of zygotic
transcription.
Next, we co-injected a pair of morpholino oligonucleo-
tides (MOs) that targeted the translational start site and
5’ untranslated region (5’UTR) of znf143 mRNA in order
to reduce protein levels during embryonic development.
Up to nearly 90% of injected embryos exhibited a range
of defects at 48 hours post fertilization (hpf) (Figure 2).
Microinjection of each individual MO resulted in the
same range of phenotypes, but at a much lower efficiency
(results not shown), supporting the assertion that the
observed phenotypes are specific to ZNF143 knockdown.
No mutant phenotypes were found when a control MO
was injected at the same concentration (results not
shown). For quantitation purposes, we sorted the mor-
phant embryos into six classes that are primarily distin-
guished by increasing severity of axial and other defects.
Class 1 embryos show a distinct kink in the tip of the tail
(Figure 2B). Class 2 embryos have the same tail kink and
also show disorganization in the somites (Figure 2C).
Class 3 embryos have a greater degree of tissue disorgani-
zation as well as significant pericardial edema (Figure
2D). Class 4 embryos have the added phenotype of severe
brain morphology defects, including absent or poorly
formed midbrain-hindbrain boundary (MHB) (Figure
2E). Class 5 embryos display the additional phenotype of
a considerably shortened axis (Figure 2F). Class 6 mor-
phants (not shown) are morphological monsters, lacking
both head and tail structures. In addition to the described
effects, we also noted reduced blood formation, rate of
circulatory flow and abnormal ear development in signifi-
cant proportions of morphant embryos falling in the
more severe classes (classes 3-6).
Early developmental stages, through most of epiboly,
proceeded normally for the ZNF143 morphant embryos,
compared to embryos injected with the control MO. How-
ever, we detected a delay of approximately 30 min to reach
bud stage. Furthermore, subsequent stages for ZNF143
morphants at 6-somite, 10-somite, 18-somite, and 22-
somite were delayed approximately one hour.
In order to verify the specificity of MO-knockdown, we
co-injected synthetic mRNA encoding zebrafish ZNF143
with the MOs to determine whether protein synthesized
from the exogenously supplied mRNA could rescue the
phenotypes. We used mRNAs encoding either full length
ZNF143 or a truncated variant lacking the transcription
activation domains (Δ2-225) in our rescue assays. Both
mRNAs lack the normal 5’UTR sequence and encode a
myc tag at the amino-terminus of the protein, such that
the morpholinos will not block their expression. We first
confirmed that the full-length myc-tagged protein is
functional for transcriptional activation in transfected
ZF4 cells (Figure 3A, compare lanes 2 and 3 with lanes 4
and 5). In addition, the Δ2-225 protein was defective for
transcriptional activation in transfected ZF4 cells (Figure
3A, lanes 6 and 7). We detected nearly equivalent levels
of expression of the myc-tagged full-length and Δ2-225
proteins in transfected HEK293 cells (Figure 3B). Thus,
our constructs should be expressed at equivalent levels
when expressed in embryos, even though for unknown
reasons we have been unable to detect these proteins by
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Figure 1 Identification of transcriptional activating domain at the amino-terminus of zebrafish ZNF143. (A) Primary structure of zebrafish
ZNF143. Numbers on top depict the amino acids at the beginning and end of prominent primary structure features of the protein. Numbers in
parentheses are percentages of identical amino acid residues between the zebrafish and human proteins for various regions of primary structure.
(B) HEK293 cells were transfected with 200 ng of pGL3/G5AdMLT firefly luciferase reporter plasmid, 10 ng of the particular pCI/GAL4DBD/
zZNF143 effector plasmid DNA noted in the figure, and 200 ng of pRL-SV40 renilla luciferase reporter. The fold-activation was determined by
comparing the firefly luciferase/renilla luciferase ratios for each sample to that ratio for samples where no effector plasmid was added. Bar height
shows the mean number from different transfected samples (number of experiments reported in parentheses), and the error bar represents the
standard deviation from the mean. Double asterisks signify p-value <0.01, and single asterisks signify a p-value <0.05 relative to samples
transfected with GAL4DBD only. The panel below shows the relative expression of each GAL4DBD/zZNF143 fusion protein in HEK293 cells by
immunoblot analysis using anti-GAL4DBD antibodies. (C) Zebrafish ZF4 cells were transfected, and relative expression levels analyzed exactly as
described for (B). We were unable to detect GAL4DBD/zZNF143 fusion proteins in transfected ZF4 cells, possibly because of the much lower
transfection efficiency compared to HEK293 cells.
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their myc-tags in injected embryos and in transfected
ZF4 cells. Importantly, when co-injected with the MOs,
full-length zebrafish ZNF143 rescued the general mor-
phant phenotypes in approximately 70% of the injected
embryos, and the remaining defects were primarily the
least severe classes (Figure 3C, compare columns 1 and
2). The rescue was dependent on the presence of the
amino-terminal region of zebrafish ZNF143 containing
both activation domains, since co-injection of mRNA
lacking codons 2-225 did not rescue the morphant phe-
notypes (Figure 3C, column 3). These results show that
the amino-terminal myc tag does not inactivate the func-
tion(s) of zebrafish ZNF143 in vivo, and the observed
MO-induced phenotypes are specific to the loss of
Figure 2 MO-induced knockdown of ZNF143 produces multiple phenotypes in zebrafish embryos. Zebrafish embryos were injected with
a combination of “Start” and “5’UTR” morpholino oligonucleotides, each at 2 ng/nL. ZNF143 morphants at approximately 48 hpf are displayed
according to increasing level of severity of axial development and other defects as described in the text (classified 1-5, respectively).
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Figure 3 Rescue of MO phenotypes by co-injection of synthetic zebrafish ZNF143 mRNA. (A) Transcriptional activation of myc-tagged
zebrafish ZNF143 deletion proteins in transfected ZF4 cells. Cells were transfected with 200 ng of firefly luciferase reporter plasmid, plus 200 ng
of pRL-SV40 renilla luciferase reporter plasmid, plus various ZNF143 effector plasmids as noted in the figure at 5 ng (columns 2, 4, 6) or 25 ng
(columns 3, 5, 7). Fold-activation was determined by comparing the firefly/renilla luciferase ratio for each sample to that ratio for the sample
shown in column 2. Bar height shows the mean number from different experiments, and error bars report the standard deviation from the
mean (when n = 3), or the range (when n = 2). Double asterisks signify a p-value <0.01, and single asterisks signify a p-value <0.05 relative to
samples transfected with vector only (lane 2). (B) Relative expression of myc-tagged zebrafish ZNF143 proteins in transfected HEK293 cells. (C)
Zebrafish embryos were injected with a combination of “Start” and “5’UTR” MOs along with either no RNA (MOs only), synthetic mRNA encoding
wt zebrafish ZNF143 (MOs + FL), or synthetic mRNA encoding zebrafish ZNF143/Δ2-225 (MOs + Δ2-225). Embryos were scored as either dead,
wt, or classes 1-6 (see Figure 2 for examples of these classifications) at 48 hpf. Results were averaged from three separate injection experiments
for each condition (approximately 100 embryos per injection). The ranges in % wt phenotype for each condition in various experiments were:
MOs only: 9-11%; MOs + FL: 69-72%; MOs + Δ2-225: 11-15%.
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ZNF143 function and more specifically to ZNF143 tran-
scriptional regulatory capability.
pax2a expression is compromised after ZNF143
knockdown
To determine whether the general morphological defects
of ZNF143 morphants could be correlated with specific
changes in gene expression, we performed whole mount
in situ hybridization to detect developmental gene expres-
sion in morphant embryos at several stages. Using goose-
coid (gsc) and orthodenticle homolog 2 (otx2) probes to
monitor prechordal plate mesoderm and neuroectoderm
[24,25], respectively, during gastrulation (shield stage and
75% epiboly for gsc, and 75% epiboly for otx2), we detected
no differences between ZNF143 morphants and embryos
injected with a control MO (results not shown). In addi-
tion, hindbrain development of rhombomeres 3 and 5
appeared normal during early somitogenesis (6- and 10-
somite stages) using an early growth response 2a (egr2a;
or krox20) probe [26], although a delay in staining of
rhombomere 5 was apparent in the 6-somite embryos
(results not shown). This minor variation is consistent
with the overall delay detected. Furthermore, we examined
the expression of myoD, a marker for somitic muscle [27].
At all stages examined, we detected no discernable differ-
ence between wt and ZNF143 morphant embryos (5-6
somite, n = 20; 16 somite, n = 13; 27 hpf, n = 20; data not
shown). Next we analyzed the expression of gata1, a mar-
ker for hematopoietic progenitors [28], since blood devel-
opment is compromised in ZNF143 morphants. At the
16-somite stage, gata1 labels populations of hematopoietic
progenitors in the posterior mesoderm flanking the mid-
line (Figure 4A). Consistent with our observation that
blood specification is aberrant, ZNF143 morphants exhib-
ited a significant reduction in gata1 expression at this
stage (Figure 4B; 50% penetrance, n = 20). At 24 hpf,
gata1 is expressed in cells of the intermediate cell mass
(ICM; Figure 4C), but expression continued to be reduced
significantly in ZNF143 morphants (Figure 4D; 37% pene-
trance, n = 19). Thus, the reduction in blood cells we
observed in ZNF143 morphants correlates with a signifi-
cant reduction in gata1 expression that labels hematopoie-
tic progenitors.
We next analyzed expression of cardiac myosin light
chain 2 (cmlc2), a marker for cardiomyocytes, since
heart development appeared disrupted after reduction of
ZNF143. At 24 hpf, the heart comprises a tube that
loops toward the left side of the embryo (Figure 4E).
Heart progenitors formed normally in ZNF143 depleted
embryos, but morphogenesis of the heart was severely
compromised in 55% of MO-injected embryos (Figure
4F, 4G; n = 38). Phenotypic defects varied in this group
from a failure to migrate to the left side of the embryo
(Figure 4F), to a failure in tube morphogenesis (Figure
4G). These phenotypic defects in the ZNF143 mor-
phants are not a result of prolonged delay of heart
development, because embryos probed for cmlc2 expres-
sion at 30 hpf and 37 hpf did not exhibit normal asym-
metric looping (26/27 defective). At these later stages,
26% displayed cardia bifida (Figure 4H, 4I).
Because ZNF143 morphants displayed morphological
abnormalities in the brain, including defects in the MHB,
we analyzed the expression of pax2a, a critical regulator of
MHB formation. At the 16-somite stage, pax2a expression
marks the optic stalks, mid-hindbrain domain, otic vesi-
cles, pronephros and a small number of spinal cord neu-
rons (Figure 4J). After reduction of ZNF143 function,
pax2a expression was reduced in most expression
domains of the majority of embryos (68%, n = 19). Expres-
sion of pax2a in the MHB was reduced substantially in
ZNF143 morphants, and to a lesser degree, expression in
the otic vesicles, and pronephros (Figure 4K, 4L). In con-
trast, expression in the optic stalks did not appear to be
significantly diminished compared to wt. Importantly, this
phenotype was rescued by coinjection of wt ZNF143
mRNA (100% rescue, n = 14). At earlier stages (bud, 6-
somite, 10-somite) pax2a expression was comparable
between ZNF143 morphants and embryos injected with
control MO. Furthermore, by 24 hpf, pax2a expression
was not significantly different between wt and ZNF143
morphants, with the exception that pax2a expression in a
group of hindbrain neurons was reduced or absent in the
morphants (Figure 4M, 4N, arrows; 100% penetrance, n =
18). Thus, normal pax2a expression, particularly at the
MHB, depends on ZNF143 function.
The zebrafish pax2a gene promoter contains binding
sites for ZNF143 and is controlled by this protein in
transfected cells
Since pax2a gene expression was affected after ZNF143
knockdown, we investigated whether this transcription
factor might control zebrafish pax2a transcription.
Visual inspection of the proximal promoter region
sequence indicated three possible SPH motifs (Figure
5A). Radiolabeled probes were prepared that contained
either the SPH1 element alone (-289/-131 fragment), or
both SPH2 and SPH3 sites (-154/+16 fragment). Both
probes bound human ZNF143, showing a single com-
plex that was competed with a specific human U6-1
SPH oligonucleotide, but not with an unrelated
sequence containing the octamer (OCT) transcription
control element (Figure 5B). Specific oligonucleotide
competition for the pax2a DNA fragments was similar
to that for the zebrafish U6 small nuclear RNA gene
promoter used as a positive control for these experi-
ments (Figure 5B, rightmost panel; [29]). Since only a
single complex dependent on addition of a nonsaturat-
ing amount of ZNF143 was detected with the - 154/+16
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fragment, we suspected that only one of the two poten-
tial SPH elements was bound. DNaseI footprinting was
used to determine which SPH element in the - 154/+16
fragment was bound by the protein. Results from foot-
printing experiments demonstrated binding of the
human ZNF143 DNA-binding domain to the SPH2 ele-
ment, while the SPH3 site was unoccupied at concentra-
tions used for the experiment (Figure 5C. left panel).
Therefore, two sites (SPH1 (likely) and SPH2) within
the zebrafish pax2a promoter are bound by ZNF143 in
vitro.
Next we investigated the transcriptional effect of the
SPH sites in the zebrafish pax2a promoter in transient
transfection experiments. Luciferase reporter plasmids
containing either the wt pax2a promoter (-289/+16),
single SPH1 or SPH2 mutants, or the double SPH1/2
mutant were added to zebrafish ZF4 cells. All mutant
sites destroyed the highly conserved CCCA sequence of
a SPH element (mutant sequences are shown in Meth-
ods). The efficacy of the SPH2MUT alteration was
demonstrated by the obliteration of the DNaseI foot-
print in vitro (Figure 5C, lanes 6-9). The zebrafish
pax2a proximal promoter (-289/+16) was quite active in
transfected ZF4 cells since a typical experiment yielded
approximately 7-fold higher normalized firefly luciferase
level than from a simple TATA box only promoter (G5
reporter in Figure 3A). In transfected ZF4 cells, using a
synthetic promoter containing multiple SPH elements,
we found only low, basal activity at the same level as
from a promoter lacking SPH sites (Figure 3A, compare
columns 1 and 2). In human HEK293 cells the SPH5
promoter activity is approximately 20-fold higher than
Figure 4 Expression analysis of ZNF143 requirement during embryonic development. In situ hybridizations to detect gata1 (A-D), cmlc2
(E-I), and pax2a (J-N) expression. (A, C, E, J, M) Wild-type. (B, D, F, G, H, I, K, L, N) ZNF143 morphants. (A, B) 16 somite stage, flat mounted
embryos, dorsal view, anterior left. Brackets indicate gata1+ hematopoietic progenitors. Note reduced expression in the morphant (B). (C, D) 24
hpf, lateral views of tails. Note reduced gata1 expression in the ICM (arrows) of ZNF143 morphants (D) compared to wt (C). (E-G) approximately
27 hpf, dorsal views, anterior up. Note heart laterality in wt (E). (F, G) Two different phenotypes observed in ZNF143 morphants. While they
show differences in tube morphogenesis, both lack laterality. (H, I) approximately 37 hpf, dorsal views, anterior up. Two different phenotypes in
ZNF143 morphants. (J-L) 16 somite stage, flat mount, dorsal view, anterior left. Compared to the wt (J), ZNF143 morphants (K, L) display
reduced pax2a expression in the pronephros (arrowheads), otic vesicles (arrows) and MHB (brackets). Note that expression in these domains is
reduced in the morphants even though expression in the optic stalks is similar to wt (asterisks). (M, N) Approximately 27 hpf, dorsal views,
anterior left. Expression of pax2a appears largely normal in ZNF143 morphants (N), with the exception of a substantial decrease in expression in
hindbrain neurons (arrows). Scale bars: 100 μm in J-L, 200 μm in M, N.
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Figure 5 ZNF143 binds to the zebrafish pax2a promoter in vitro. (A) Map of zebrafish pax2a proximal promoter showing three potential
SPH sites. The sequences of the potential SPH sites are compared to the zebrafish U6-1 element [29] and the consensus SPH sequence from
[37]. Capital letters depict nucleotides matching the consensus. To facilitate binding assays two separate radiolabeled zebrafish pax2a probes
were prepared by PCR as diagrammed. (B) Electrophoretic mobility shift assay. Approximately 3 fmol of radiolabeled probes depicted in (A) were
incubated with 3 μL of human ZNF143-(88-638) expressed by in vitro transcription/translation (lanes 3-9; 12-18; 21-24) or with unprogrammed
extract (lanes 2, 11, 20), and electrophoresed. In addition, in samples shown in lanes 4-6, 13-15, and 22-24, an unlabeled double-stranded
oligonucleotide with the sequence including the human U6-1 SPH element was added with the labeled probe in amounts noted, or similarly, an
unlabeled oligonucleotide containing the unrelated, OCT sequence was added to samples in lanes 7-9 and 16-18. (C) DNase I footprinting assay.
Approximately 3 fmol of singly end-labeled zebrafish pax2a probe from -154 to +16 were incubated with amounts of purified human ZNF143
DBD protein as indicated. The wt pax2a promoter was used for samples in lanes 1-5, whereas SPH2 or SPH3 mutant promoters were used for
samples in lanes 6-9, or lanes 10-13, respectively.
Halbig et al. BMC Molecular Biology 2012, 13:3
http://www.biomedcentral.com/1471-2199/13/3
Page 8 of 13
from the G5 promoter (unpublished results). Hence,
unlike HEK293 cells, ZF4 cells do not contain sufficient
amounts of active ZNF143 to stimulate potentially
responsive promoters. Transcription from the wt pax2a
promoter was increased almost two-fold by co-transfec-
tion with a ZNF143 expression plasmid (Figure 6). The
SPH2MUT and doubly mutant promoters were not acti-
vated, whereas the relative stimulation of transcription
from the SPH1MUT promoter was somewhat reduced
(Figure 6, filled bars). Not surprisingly, transcription
from the various SPHMUT pax2a promoters was not
reduced significantly in the absence of exogenous
ZNF143 (unfilled bars in Figure 6). Hence the SPH1 and
SPH2 elements are functional for transcriptional activity
directed by the zebrafish pax2a gene promoter.
Discussion
In this study, we show that MO-induced knockdown of
ZNF143 results in many phenotypic effects during zeb-
rafish development. General defects in tail formation
were obvious, but we also noticed abnormal heart,
blood, ear and MHB development. The specificity of the
MO-induced phenotypes was confirmed by experiments
showing phenotypic rescue by the full-length protein
Figure 6 SPH sites in the zebrafish pax2a promoter are functional for transcription in transfected ZF4 cells. Zebrafish ZF4 cells were
transfected per well with 200 ng plasmid DNA containing wt or SPHMUT pax2a promoters driving firefly luciferase expression, plus 200 ng pRL-
SV40 renilla luciferase plasmid as a normalization control, plus 25 ng of either empty vector pCI-basic plasmid (unfilled columns) or pCI/
myczZNF143 to express myc-tagged full-length ZNF143 (filled columns). The ratio of luciferase/renilla light units was determined for each
sample, and these ratios were compared relative to the wt promoter with no transfected ZNF143 plasmid included in every experiment. The
height of each column represents the average value for the number of independently transfected samples (specified in parentheses), and error
bars depict one standard deviation above and below the mean. A double asterisk signifies a p-value <0.01, and a single asterisk signifies a p-
value <0.05 comparing like reporter samples with and without addition of ZNF143 expression plasmid.
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but not a truncated variant lacking transcriptional acti-
vation domains. In the morphants, expression of gata1
(blood), cmlc2 (cardiac) and pax2a (MHB) were reduced
or altered spatially. Furthermore, we found two binding
sites for ZNF143 in the zebrafish pax2a gene proximal
promoter, and disruption of these sites reduced tran-
scription in transfected zebrafish cells. Therefore, one
likely mRNA gene target for transcriptional control by
this protein in vivo is pax2a, although the number is
probably much higher.
It is not surprising that a multitude of phenotypes
appear after ZNF143 knockdown because many vertebrate
small RNA genes contain SPH sites, and in mammals it
has been hypothesized that approximately 2000 mRNA
gene promoters contain SPH sites [5]. It seems likely that
the gene encoding ZNF143 is essential for zebrafish viabi-
lity. The number of promoters containing SPH elements
in zebrafish is unknown. Previously, we have demonstrated
an important positive role for the SPH site in zebrafish U6
snRNA gene promoters [29], and have noticed putative
SPH elements in many zebrafish small RNA gene promo-
ters (unpublished results). Many fugu small RNA gene
promoters contain SPH sites [23]. At present, we do not
know which phenotypic effects or the relative severity of
those effects caused by ZNF143 knockdown are the result
of altered expression of small RNA genes or mRNA genes.
Since knockdown was rescued by coinjection of synthetic
mRNA encoding full-length ZNF143, but not by RNA
lacking coding potential for N-terminal activation domains
(Figure 3), we hope to be able to distinguish differential
effects of mRNA-activation vs. small RNA activation by
this protein using rescue with synthetic RNA encoding
deletions or mutations in those separable activation
functions.
Since knockdown of ZNF143 caused relatively drastic
phenotypic effects in zebrafish embryos, we were surprised
that cultured zebrafish ZF4 cells contain undetectable
levels of endogenous active protein in a transactivation
assay (Figure 3A, compare reporter gene expression from
G5 promoter vs. SPH5 promoter in columns 1-3). When
these same reporter constructs were used in transfected
human HEK293 cells the SPH5 promoter was transcribed
at approximately 20-fold higher level due to endogenous
ZNF143. Perhaps a small amount of ZNF143 in ZF4 cells
is sufficient for their growth, and that amount is below a
threshold detectable with relatively large amounts of
reporter plasmid added in the transfection experiments.
Indeed, mRNA encoding this protein in ZF4 cells was
detected by RT-PCR (results not shown). Another possibi-
lity is that relative overexpression of ZNF143 in trans-
fected cells suppresses another defect in the small RNA
activation pathway in ZF4 cells. Nevertheless, the nonsa-
turating levels of active ZNF143 in ZF4 cells allowed us to
use them as an assay for mRNA activation potential of
tagged protein and protein lacking activation domains
(Figure 3A), and we will use this assay in the future to
examine activity of mutant proteins.
Our experiments demonstrating brain defects and, spe-
cifically, reduced pax2a expression upon ZNF143 knock-
down induced us to inspect the pax2a proximal promoter
for SPH sites. Indeed, ZNF143 binds to the pax2a promo-
ter in vitro and activates it in an SPH-site dependent man-
ner when cotransfected into ZF4 cells. Although we used
existing human ZNF143 protein reagents in our laboratory
for the binding studies, rather than the zebrafish protein,
we expect that nucleotide specificity of the human and
zebrafish proteins should be undistinguishable. The zinc
finger DNA-binding domains are 91% identical, with no
changes in the amino acid residues known to be most
important for DNA recognition by this motif [23,29,30].
Although the enhancer(s) of the zebrafish pax2a gene pro-
moter have been characterized partially [31], we are not
aware of previous work to investigate elements within the
proximal promoter. We expect that other elements in
addition to the SPH1 and SPH2 sites constitute this pro-
moter. Luciferase reporter gene activity of the SPH1+2
mutant promoter was approximately 7-fold higher than
that found with a simple TATA-containing promoter in
our transient transfection assays (unpublished results).
This promoter does not contain a readily identifiable
TATA box, a characteristic that is true also of most pre-
viously identified SPH-containing mammalian mRNA
gene promoters [5]. It will be interesting to dissect the
pax2a promoter further in order to discern relative roles
of SPH elements and other elements with respect to both
basal transcription and enhancer-driven expression.
Because of the widespread abundance of SPH sites in
mammalian mRNA gene promoters, we searched for
them in other important developmental regulators in
addition to pax2a. Although several SPH sites appeared
to be candidates in the zebrafish gata1 proximal promo-
ter, none bound ZNF143 in vitro (unpublished results).
On the other hand, we have found a high-affinity SPH
element in the zebrafish fibroblast growth factor recep-
tor-1 (fgfr1) and glycogen synthase kinase 3a promoters
(unpublished results). Whether any of the aforemen-
tioned genes is controlled in a significant manner by
ZNF143 will require further study. Furthermore, because
of the large potential number of target promoters in
mammals, it is highly likely that the transcription of
many other developmental regulator genes is controlled
by ZNF143.
Conclusions
Because knockdown of the transcriptional activator
ZNF143 by injection of translational-blocking MOs
causes many significant phenotypic effects in zebrafish
embryos, we conclude that this protein is essential for
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normal development. Phenotypic effects are rescued by
coinjection of full-length znf143 mRNA, but not by
mRNA lacking coding capacity for the N-terminal
region containing activation domains. Hence, the MO-
mediated knockdown is specific, and ZNF143 function
in vivo requires the N-terminal region. Furthermore, the
pax2a gene promoter is at least one likely target of
ZNF143 during zebrafish development.
Methods
Plasmid constructions
A cDNA containing the zebrafish znf143 gene was
obtained from Open Biosystems. We named this plasmid
pME18S-FL3/zZNF143. The open reading frame (ORF)
contained within this insert was lacking a full-length gene
and contained a reading frame error in the coding region
near the amino-terminus of the encoded protein. Hence,
in order to construct a full-length ORF situatated behind a
T7 promoter, three DNA fragments were ligated as fol-
lows. The “correct” amino-terminal region fragment was
prepared by reverse transcriptase polymerase chain reac-
tion (RT-PCR) using total RNA from zebrafish ZF4 cells
and ligated into a pGEM-T vector (Promega). This frag-
ment was excised using KpnI and PvuII and purified by
agarose gel electrophoresis. The main body of the znf143
ORF was excised from pME18S-FL3/zZNF143 using PvuII
and XhoI and purified by agarose gel electrophoresis. The
third DNA fragment was the pBlueScript SK vector (Stra-
tagene) opened at KpnI and XhoI sites, and purified by
chromatography on Sepharose CL-4B. The three-fragment
ligation reaction was used to transform E. coli XL1-Blue
(Stratagene) competent cells. The resulting plasmid was
named pBS/zZNF143. A single myc tag was inserted at
the amino-terminus of the encoded ZNF143 protein using
the QuickChange site-directed mutagenesis protocol. The
subsequent Δ2-225 deletion within the zebrafish znf143
ORF started with the parent plasmid pBS/myczZNF143
and was constructed using the QuickChange protocol in
which the oligonucleotides base-paired across the deletion
endpoints and looped out the template DNA to be deleted.
Plasmid minipreps were prepared using a Qiagen miniprep
kit, and such preparations were suitable for mRNA synth-
esis in vitro. Zebrafish ZNF143 expression plasmids used
for transient transfection experiments were constructed by
amplifying inserts from pBS-based plasmids using PfuUl-
traHF polymerase (Stratagene), restriction with XbaI and
SalI, gel-purification, and ligation into like sites in the
pCI-neo vector (Promega). GAL4DBD - zebrafish ZNF143
fusion expression plasmids were constructed in the pCI-
neo vector (Promega), and contained inserts encoding the
amino-terminal 94 aa of S. cerevisiae Gal4p [11] fused in-
frame to zebrafish ZNF143 fragments amplified by PCR.
Luciferase reporter plasmids used for transient transfec-
tion experiments were based upon the pGL3-basic vector
(Promega) and included the adenovirus major late basal
promoter (AdMLT). The pGL3/G5AdMLT (“G5”) repor-
ter contained five copies of the S. cerevisiae upstream acti-
vating sequence galactose (UASG) element ligated
upstream of the TATA box, whereas the “SPH5” reporter
contained five copies of the human U6-1 gene SPH ele-
ment in the same position. The zebrafish pax2a gene pro-
moter (-289 to +16) was amplified from genomic DNA by
PCR and ligated into the pGEM-T vector (Promega). The
location of the transcriptional start site (+1) is according
to the 5’-most expressed sequence tag (EST) in the Uni-
versity of California, Santa Cruz zebrafish genome assem-
bly (July 2007 assembly, chromosome 13, position
29,268,562). SPHMUT plasmids containing clustered
point mutations within SPH sites of the pax2a promoter
were prepared by the QuickChange protocol. The nucleo-
tide changes introduced into SPHMUT sites were (mutant
nucleotides in lower case letters): SPHMUT1: 5’-TAA-
gatcTCTCTCCTCAT-3’; SPH2MUT: 5’-CTagatctATCC
CCCCTC-3’ (bottom strand); SPH3MUT: 5’-CAagatc-
tAGCTTCTAAC-3’ (top strand). DNA fragments contain-
ing wt and mutant pax2a promoters were amplified by
PCR using pGEM-based templates, restricted with SacI
and NheI, and ligated into the same sites of the pGL3-
basic vector. Inserts of all plasmids were sequenced com-
pletely to verify deletions, in-frame ligations, and ensure
that no other mutations were added to the znf143 ORF or
pax2a promoter. DNAs used for transient transfection
experiments were purified using the Qiagen plasmid maxi
kit, and concentrations were determined by absorbance at
260 nm.
Cell culture, transfection, and reporter gene assays
Human HEK293 cells were purchased from ATCC (CRL-
1573) and cultured in Dulbecco’s Modified Eagle Medium
(DMEM), containing high glucose (Gibco 11995), penicil-
lin-streptomycin, and 10% bovine growth serum
(Hyclone). Experiments with HEK293 cells were per-
formed under BSL-2 guidelines following approval by the
Texas A&M University Institutional Biosafety Committee.
Zebrafish ZF4 cells [32] were obtained from ATCC (CRL-
2050) and grown in DMEM/F12 medium (Gibco 11320),
penicillin-streptomycin, and 10% bovine growth serum.
Cells were transfected in 6-well dishes using Lipofecta-
mine 2000 (Invitrogen) following the manufacturer’s pro-
tocol with amounts of DNA described in the figure
legends. Cells were co-transfected with pRL-SV40 (Pro-
mega), a renilla luciferase reporter, for normalization. 48 h
post-transfection, cell extracts were prepared, and firefly
and renilla luciferase activities were measured with a Sirius
tube luminometer (Berthold) using reagents and protocols
from the Dual-Luciferase Reporter Assay System (Pro-
mega). The number of independently transfected samples
for each condition is shown in parentheses above the bars
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in the graphs. Statistical significance (p-values) comparing
sets of different experiments was calculated using the Stu-
dent’s T test in Microsoft Excel.
Electrophoretic mobility shift assay (EMSA) and DNaseI
footprinting
Two radiolabeled pax2a gene proximal promoter probes
used for protein-DNA binding assays were prepared by
PCR using either 32P-end-labeled CZPAX2A-131 primer
(5’-CAACACTTTGTGATTCGCCAACGC-3’), and unla-
beled ZPAX2A-289 primer (5’-TGGTACCGCTTCCTTT
CCACTTGT-3’), or 32P end-labeled CZPAX2A+16 primer
(5’-ATGTGCCTGTTAGAAGCTTTGGGC-3’) and unla-
beled ZPAX2A-154 primer (5’-GCGTTGGCGAATCA-
CAAAGTGTTG-3’), and pGEM plasmid DNA with wt or
SPHMUT pax2a promoter inserts. The zebrafish U6-1
probe was prepared as described [29]. Protein for
EMSA experiments was prepared by in vitro transcription/
translation of human znf143 as described previously [9].
DNA-protein complex formation, competition with oligo-
nucleotides, and electrophoresis on non-denaturing gels
were performed as before [33]. Sequences of the competi-
tor oligonucleotides can be found in [2] where human U6-
1 SPH is called NONOCT(long) and human U6-1 OCT is
called OCTCON. DNaseI footprinting assays followed the
same protocol as described previously [33], using purified
human ZNF143 zinc finger DNA-binding domain (DBD)
(amino acids 236-444) expressed from a pET5a vector in
E. coli [29]. The positions of the putative SPH elements
were deduced by electrophoresis of T and C dideoxy
sequencing reactions on the same gels.
Zebrafish husbandry and embryo microinjection
AB strain zebrafish were maintained using standard meth-
ods [34], and with protocols approved by the Texas A&M
Animal Care and Use Committee (AUP #2007-90 and
2010-90). MOs and synthetic mRNAs were injected at the
one- to two-cell stage. Two MOs were designed to block
the translation of zebrafish znf143, dissolved in 1X
Danieau buffer, and were coinjected at a concentration of
2 ng/nL, each. The “Start” MO, ordered from Open Bio-
systems and Gene Tools, LLC, had the sequence, 5’-ATT-
CACCTGGGCTAACAGCATGATC-3’, and the “5’UTR”
MO, ordered from Gene Tools, LLC, had the sequence, 5’-
CAACAATCCCTTCGTTCGACCACCA-3’. The control
MO (5’-CCTCTTACCTCAGTTACAATTTATA-3’) was
purchased from Gene Tools, LLC. For rescue coinjection
experiments, capped and polyadenylated mRNAs were
synthesized from pBS/myczZNF143 or the Δ2-225 dele-
tion variant template using the mMESSAGE mMACHINE
T7 Ultra kit (Ambion). Synthetic mRNA concentrations
were determined using a NanoDrop spectrophotometer.
Approximately 3 nL of RNAs were injected at a concen-
tration of 30 pg/nL, an amount that did not cause any
toxicity or phenotype when injected without MOs. Pheno-
types were classified for quantitation in Figure 3C at 48
hpf.
Immunoblots
Nuclear extracts from HEK293 cells were prepared
using the NE-PER kit (Pierce/Thermo Scientific). After
electrophoresis on standard SDS denaturing gels, pro-
teins were transferred to nitrocellulose, and probed with
rabbit anti-yeast GAL4DBD (Upstate/Millipore), or
mouse monoclonal anti-myc (Upstate/Millipore, clone
4A6).
Whole-mount in situ hybridization
Whole-mount in situ hybridizations with embryos were
performed according to standard methods [26]. Probes
used were cmlc2 [35], pax2a [36], gata1 [28], myoD
[27], gsc [24], otx2 [25], and egr2a (or krox20) [26]. The
numbers of independently injected embryos scored for
various phenotypes are noted in the text.
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